Biotechnology - Asia-Pacific, Sanofi

Filter

Current filters:

Asia-PacificSanofi

Popular Filters

New Zealand to widen access for type 1 and type 3 Gaucher disease drug

07-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of a proposal to widen…

Asia-PacificBiotechnologyCerezymeGenzymePharmaceuticalRare diseasesRegulationSanofi

Sanofi MS drug Aubagio gets second approval, in Australia

21-11-2012

Having already gained approval in the largest global pharma market, the USA, French drug major Sanofi's…

Asia-PacificAubagioBiotechnologyGenzymeNeurologicalPharmaceuticalRegulationSanofi

Alnylam gets upfront $22.5 million in RNAi link with Genzyme

23-10-2012

French drug major Sanofi's (Euronext: SAN) US biotech subsidiary Genzyme has entered into an exclusive…

Alnylam PharmaceuticalsAsia-PacificBiotechnologyGenzymeLicensingPharmaceuticalRare diseasesSanofi

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top